NO840214L - Fremgangsmaate for fremstilling av terapeutisk aktive diazoterte heterocykliske forbindelser - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive diazoterte heterocykliske forbindelser

Info

Publication number
NO840214L
NO840214L NO840214A NO840214A NO840214L NO 840214 L NO840214 L NO 840214L NO 840214 A NO840214 A NO 840214A NO 840214 A NO840214 A NO 840214A NO 840214 L NO840214 L NO 840214L
Authority
NO
Norway
Prior art keywords
diazotated
procedure
preparation
image
heterocyclic compounds
Prior art date
Application number
NO840214A
Other languages
English (en)
Other versions
NO159170B (no
NO159170C (no
Inventor
Kathleen Biziere
Jean-Pierre Chambon
Andre Hallot
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO840214L publication Critical patent/NO840214L/no
Publication of NO159170B publication Critical patent/NO159170B/no
Publication of NO159170C publication Critical patent/NO159170C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Catalysts (AREA)
  • Polymerisation Methods In General (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO840214A 1983-01-21 1984-01-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive diazin-forbindelser. NO159170C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8300954A FR2539741A1 (fr) 1983-01-21 1983-01-21 Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Publications (3)

Publication Number Publication Date
NO840214L true NO840214L (no) 1984-07-23
NO159170B NO159170B (no) 1988-08-29
NO159170C NO159170C (no) 1988-12-07

Family

ID=9285183

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840214A NO159170C (no) 1983-01-21 1984-01-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive diazin-forbindelser.

Country Status (30)

Country Link
US (1) US4624952A (no)
EP (1) EP0114770B1 (no)
JP (1) JPS59137469A (no)
KR (1) KR910000640B1 (no)
AT (1) ATE28453T1 (no)
AU (1) AU563160B2 (no)
CA (1) CA1217490A (no)
CS (1) CS242894B2 (no)
DD (1) DD216014A5 (no)
DE (1) DE3464909D1 (no)
DK (1) DK25684A (no)
EG (1) EG16212A (no)
ES (1) ES8407040A1 (no)
FI (1) FI79537C (no)
FR (1) FR2539741A1 (no)
GR (1) GR79766B (no)
HU (1) HU191586B (no)
IE (1) IE56569B1 (no)
IL (1) IL70740A (no)
MA (1) MA20007A1 (no)
NO (1) NO159170C (no)
NZ (1) NZ206906A (no)
OA (1) OA07638A (no)
PH (1) PH21060A (no)
PL (1) PL143224B1 (no)
PT (1) PT77966B (no)
SG (1) SG2189G (no)
SU (1) SU1342415A3 (no)
YU (1) YU10384A (no)
ZA (1) ZA84342B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
DE3517617A1 (de) * 1985-05-15 1986-11-20 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
US5656631A (en) * 1989-02-07 1997-08-12 Sanofi Pyridazine derivatives
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US8575167B2 (en) * 2007-02-06 2013-11-05 Takeda Pharmaceutical Company Limited Spiro compounds having stearoyl-CoA desaturase action
KR102604425B1 (ko) * 2015-04-29 2023-11-22 난징 산홈 팔마세우티칼 컴퍼니 리미티드 키나아제 억제제로 사용되는 융합 고리 또는 트리시클로아릴피리미딘 화합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
US4302455A (en) * 1980-04-14 1981-11-24 Merck & Co., Inc. 2-(4-Aminopiperidino)pyrazines
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2511366A1 (fr) * 1981-08-11 1983-02-18 Sanofi Sa Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Also Published As

Publication number Publication date
CS42484A2 (en) 1985-08-15
FI79537B (fi) 1989-09-29
KR840007406A (ko) 1984-12-07
EG16212A (en) 1989-06-30
ES528921A0 (es) 1984-09-01
EP0114770B1 (en) 1987-07-22
IL70740A0 (en) 1984-04-30
IL70740A (en) 1986-09-30
PL245836A1 (en) 1985-07-02
PT77966B (fr) 1986-07-11
PT77966A (fr) 1984-02-01
HU191586B (en) 1987-03-30
PH21060A (en) 1987-07-10
FI840238A (fi) 1984-07-22
NO159170B (no) 1988-08-29
CS242894B2 (en) 1986-05-15
EP0114770A3 (en) 1984-08-22
EP0114770A2 (fr) 1984-08-01
FR2539741B1 (no) 1985-05-17
DK25684A (da) 1984-07-22
FI79537C (fi) 1990-01-10
AU2323684A (en) 1984-07-26
CA1217490A (en) 1987-02-03
MA20007A1 (fr) 1984-10-01
ES8407040A1 (es) 1984-09-01
IE56569B1 (en) 1991-09-11
FI840238A0 (fi) 1984-01-20
GR79766B (no) 1984-10-31
DD216014A5 (de) 1984-11-28
JPS59137469A (ja) 1984-08-07
NO159170C (no) 1988-12-07
AU563160B2 (en) 1987-07-02
ATE28453T1 (de) 1987-08-15
NZ206906A (en) 1987-05-29
US4624952A (en) 1986-11-25
KR910000640B1 (ko) 1991-01-31
OA07638A (fr) 1985-05-23
PL143224B1 (en) 1988-01-30
DE3464909D1 (en) 1987-08-27
DK25684D0 (da) 1984-01-20
ZA84342B (en) 1984-08-29
YU10384A (en) 1986-10-31
IE840102L (en) 1984-07-21
FR2539741A1 (fr) 1984-07-27
SG2189G (en) 1989-06-02
SU1342415A3 (ru) 1987-09-30

Similar Documents

Publication Publication Date Title
IT1063768B (it) Procedimento perfezionato per la fabbricazione di dispositivi semiconduttori
NO840214L (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazoterte heterocykliske forbindelser
IT1116695B (it) Procedimento per la preparazione di ammidi di acidi da corrispondenti nitrili
BE593463A (fr) Procédé de préparation de dérivés N-substitués d'amino-norcamphane à activité analeptique.
FR2327995A1 (fr) Procede ameliore de preparation de vanadate d'ethyle
FR2314192A1 (fr) Procede de preparation d'oxaphospholannes-1,2
FR2308638A1 (fr) Procede de preparation de n-(a-substituees-o-aminoalcyl)-1 desoxy-3 ribostamycines
OA05404A (fr) Procédé de préparation de composés pharmocologiquement actifs.
BE837906A (fr) Procede de preparation de n-(alpha-alcoxyethyl)-carboxamides
BE609074R (fr) Procédé de préparation de dérivés N-substitués d'amino-norcamphane à activité analeptique
OA05206A (fr) Procédé de préparation de dérivés d'amines.
FR2306198A1 (fr) Procede discontinu de preparation de l'iminodiacetonitrile
PT65165A (fr) Noveau procede de preparation du n-(1-ethyl-2-pyrrolidylmethyl)-2-methoxy-5-sulfamoyl-benzamide
IL50247A0 (en) Process for the preparation of 3-(3, 5-dichlorophenyl)-hydantoin
AR212635A1 (es) Procedimiento de preparacion de n-(1'-alilpirrolidinil-2'-metil)-2-metoxi-4,5-azimidibenzamida
FR2317307A1 (fr) Procede de preparation d'oxaphospholannes-1,2
RO69914A (ro) Procedeu pentru prepararea 1-benzoil-2-(2',6'-diclorfenilamino5-2-imidazolinei
FR2336377A1 (fr) Procede de preparation de la n-(3,4-dimethylphenyl)-d-ribamine
BE845878A (fr) Procede de preparation directe d'alpha-amino y -cetoacides n-acyles etcomposes correspondants
FR2349572A1 (fr) Procede perfectionne de preparation de n-(carbamoyl n-substitue-n', n'-dialcoylamidino)-n-methylcarbamates d'alcoyle
BE849390A (fr) Procede de preparation de la n-(3,4-dimethylphenyl)-d-ribamine